Cargando…
Corrigendum to “Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost” [Biochem. Pharmacol. 178 (2020) 114057]
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533109/ https://www.ncbi.nlm.nih.gov/pubmed/33027739 http://dx.doi.org/10.1016/j.bcp.2020.114249 |
| _version_ | 1783590065630347264 |
|---|---|
| author | Mohammed El Tabaa, Manar Mohammed El Tabaa, Maram |
| author_facet | Mohammed El Tabaa, Manar Mohammed El Tabaa, Maram |
| author_sort | Mohammed El Tabaa, Manar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7533109 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75331092020-10-05 Corrigendum to “Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost” [Biochem. Pharmacol. 178 (2020) 114057] Mohammed El Tabaa, Manar Mohammed El Tabaa, Maram Biochem Pharmacol Corrigendum Elsevier Inc. 2020-12 2020-10-04 /pmc/articles/PMC7533109/ /pubmed/33027739 http://dx.doi.org/10.1016/j.bcp.2020.114249 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Corrigendum Mohammed El Tabaa, Manar Mohammed El Tabaa, Maram Corrigendum to “Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost” [Biochem. Pharmacol. 178 (2020) 114057] |
| title | Corrigendum to “Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost” [Biochem. Pharmacol. 178 (2020) 114057] |
| title_full | Corrigendum to “Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost” [Biochem. Pharmacol. 178 (2020) 114057] |
| title_fullStr | Corrigendum to “Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost” [Biochem. Pharmacol. 178 (2020) 114057] |
| title_full_unstemmed | Corrigendum to “Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost” [Biochem. Pharmacol. 178 (2020) 114057] |
| title_short | Corrigendum to “Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost” [Biochem. Pharmacol. 178 (2020) 114057] |
| title_sort | corrigendum to “targeting neprilysin (nep) pathways: a potential new hope to defeat covid-19 ghost” [biochem. pharmacol. 178 (2020) 114057] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533109/ https://www.ncbi.nlm.nih.gov/pubmed/33027739 http://dx.doi.org/10.1016/j.bcp.2020.114249 |
| work_keys_str_mv | AT mohammedeltabaamanar corrigendumtotargetingneprilysinneppathwaysapotentialnewhopetodefeatcovid19ghostbiochempharmacol1782020114057 AT mohammedeltabaamaram corrigendumtotargetingneprilysinneppathwaysapotentialnewhopetodefeatcovid19ghostbiochempharmacol1782020114057 |